Boya Bio-Pharmaceutical Group Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

Boya Bio-Pharmaceutical Group Co., Ltd. - overview

About

Founded in 1993 and based in Fuzhou, China, Boya Bio-Pharmaceutical Group Co. , Ltd. operates as a biopharmaceutical company that focuses on the research, development, production, and sales of blood products. Xinxi Liao, chairman of the company, graduated from China Pharmaceutical University and previously worked for Jiangzhong Pharmaceutical.

It has 5 branch offices. In February 2008, Jiangxi Boya Bio-Pharmaceutical Co. Ltd. raised a pre-IPO funding for CNY 102 million.

In March 2012, the company was listed on the Shenzhen Stock Exchange. The company is mainly engaged in the research, development, production, and sales of blood products, chemical drugs, APIs, biochemical drugs, etc. The products include human albumin, human immunoglobulin, rabies immunoglobulin, etc. The products are suitable for the treatment of tumors, nephrotic syndrome, hemophilia, and other diseases.

The company generates revenue by providing blood products.

Current Investors

GTJA Investment Group

Request a demo

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.china-boya.com

Verticals

Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo